These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 7940825

  • 1. Clinical efficacy and pharmacokinetics of HMG-CoA reductase inhibitors in heart transplant patients treated with cyclosporin A.
    Regazzi MB, Iacona I, Campana C, Gavazzi A, Viganò M, Perani G.
    Transplant Proc; 1994 Oct; 26(5):2644-5. PubMed ID: 7940825
    [No Abstract] [Full Text] [Related]

  • 2. Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model.
    Meiser BM, Wenke K, Thiery J, Wolf S, Devens C, Seidel D, Hammer C, Billingham ME, Reichart B.
    Transplant Proc; 1993 Apr; 25(2):2077-9. PubMed ID: 7682363
    [No Abstract] [Full Text] [Related]

  • 3. Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia.
    Cantarell C, Bonal J, Sierra C, Pastor C, Lauzurica R, Capdevila L.
    Transplant Proc; 1995 Aug; 27(4):2222-3. PubMed ID: 7652781
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
    Richter WO, Jacob BG, Schwandt P.
    Int J Tissue React; 1991 Aug; 13(2):107-10. PubMed ID: 1955291
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative efficacy and tolerability of low-dose pravastatin versus lovastatin in patients with hypercholesterolemia.
    Strauss WE, Lapsley D, Gaziano JM.
    Am Heart J; 1999 Mar; 137(3):458-62. PubMed ID: 10047626
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Statins (HMG-CoA reductase inhibitors), cholesterol and stroke].
    Marta-Moreno J, Echeandia C, Oliveros-Cid A, Figuerola A, Mola S.
    Rev Neurol; 1998 Nov; 27(159):827-30. PubMed ID: 9859160
    [Abstract] [Full Text] [Related]

  • 16. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun 14; 153(11):1321-9. PubMed ID: 8507122
    [Abstract] [Full Text] [Related]

  • 19. Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.
    Yoshimura N, Ohmori Y, Tsuji T, Oka T.
    Transplant Proc; 1994 Oct 14; 26(5):2632-3. PubMed ID: 7940820
    [No Abstract] [Full Text] [Related]

  • 20. [New perspectives in the control of hypercholesterolemia with the use of HMG CoA reductase inhibitors].
    Ribeiro L, Kohn IJ.
    Arq Bras Cardiol; 1990 Mar 14; 54(3):177-8. PubMed ID: 2288502
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.